{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:21:51Z","timestamp":1788898911088,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00104-018-0647-9","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T12:30:27Z","timestamp":1526473827000},"page":"523-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Die Rolle der Viszeralchirurgie bei\u00a0Oligometastasierung nichtgastrointestinaler Tumoren","Role of visceral surgery in oligometastases of non-gastrointestinal tumors"],"prefix":"10.1007","volume":"89","author":[{"given":"R.","family":"Wahba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stippel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"647_CR1","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Kurzversion 4.0, 2017, AWMF Registernummer: 032-045OL, \n                    http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/mammakarzinom\/2017"},{"issue":"Suppl 7","key":"647_CR2","doi-asserted-by":"publisher","first-page":"vii11","DOI":"10.1093\/annonc\/mds232","volume":"23","author":"F Cardoso","year":"2012","unstructured":"Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii11\u2013vii19","journal-title":"Ann Oncol"},{"issue":"6","key":"647_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/01.sla.0000246847.02058.1b","volume":"244","author":"R Adam","year":"2006","unstructured":"Adam R, Aloia T, Krissat J et\u00a0al (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6):897\u2013907 (discussion 907\u2013898)","journal-title":"Ann Surg"},{"issue":"5","key":"647_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jamcollsurg.2011.12.048","volume":"214","author":"RT Groeschl","year":"2012","unstructured":"Groeschl RT, Nachmany I, Steel JL et al (2012) Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a\u00a0multi-institutional analysis. J\u00a0Am Coll Surg 214(5):769\u2013777","journal-title":"J Am Coll Surg"},{"issue":"8","key":"647_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00423-014-1241-3","volume":"399","author":"TL Fitzgerald","year":"2014","unstructured":"Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE (2014) The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a\u00a0systematic review. Langenbecks Arch Surg 399(8):989\u20131000","journal-title":"Langenbecks Arch Surg"},{"key":"647_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.breast.2017.02.003","volume":"32","author":"TG Yoo","year":"2017","unstructured":"Yoo TG, Cranshaw I, Broom R, Pandanaboyana S, Bartlett A (2017) Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a\u00a0survival benefit? Breast 32:162\u2013172","journal-title":"Breast"},{"key":"647_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-018-1746-9","author":"S Tasleem","year":"2018","unstructured":"Tasleem S, Bolger JC, Kelly ME et\u00a0al (2018) The role of liver resection in patients with metastatic breast cancer: a\u00a0systematic review examining the survival impact. Ir J Med Sci. \n                    https:\/\/doi.org\/10.1007\/s11845-018-1746-9","journal-title":"Ir J Med Sci"},{"issue":"8","key":"647_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.hpb.2016.05.014","volume":"18","author":"GA Margonis","year":"2016","unstructured":"Margonis GA, Buettner S, Sasaki K et al (2016) The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a\u00a0multi-institutional analysis. HPB (Oxford) 18(8):700\u2013705","journal-title":"HPB (Oxford)"},{"issue":"1","key":"647_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/SLA.0000000000001371","volume":"264","author":"E Sadot","year":"2016","unstructured":"Sadot E, Lee SY, Sofocleous CT et al (2016) Hepatic resection or ablation for isolated breast cancer liver metastasis: a case-control study with comparison to medically treated patients. Ann Surg 264(1):147\u2013154","journal-title":"Ann Surg"},{"issue":"1","key":"647_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-017-4309-2","volume":"165","author":"TK Yoo","year":"2017","unstructured":"Yoo TK, Chae BJ, Kim SJ et al (2017) Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery. Breast Cancer Res Treat 165(1):109\u2013118","journal-title":"Breast Cancer Res Treat"},{"key":"647_CR11","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms, Kurzversion 1.1, 2017, AWMF Registernummer: 043\/017OL, \n                    http:\/\/leitlinienprogramm-onkologie.de\/Nierenzellkarzinom.85.0.html\n                    \n                  . Zugegriffen: 01.06.2017"},{"key":"647_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.11.016","author":"T Powles","year":"2017","unstructured":"Powles T, Albiges L, Staehler M et al (2017) Updated European Association of Urology guidelines recommendations for the treatment of first-line metastatic clear cell renal cancer. Eur Urol. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.11.016","journal-title":"Eur Urol"},{"issue":"5","key":"647_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S et\u00a0al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913\u2013924","journal-title":"Eur Urol"},{"issue":"12","key":"647_CR14","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1016\/S1470-2045(14)70235-9","volume":"15","author":"S Dabestani","year":"2014","unstructured":"Dabestani S, Marconi L, Hofmann F et\u00a0al (2014) Local treatments for metastases of renal cell carcinoma: a\u00a0systematic review. Lancet Oncol 15(12):e549\u2013e561","journal-title":"Lancet Oncol"},{"issue":"6","key":"647_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MOU.0000000000000330","volume":"26","author":"S Dabestani","year":"2016","unstructured":"Dabestani S, Marconi L, Bex A (2016) Metastasis therapies for renal cancer. Curr Opin Urol 26(6):566\u2013572","journal-title":"Curr Opin Urol"},{"issue":"4","key":"647_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00268-007-0685-9","volume":"31","author":"A Thelen","year":"2007","unstructured":"Thelen A, Jonas S, Benckert C et\u00a0al (2007) Liver resection for metastases from renal cell carcinoma. World J Surg 31(4):802\u2013807","journal-title":"World J Surg"},{"issue":"4","key":"647_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00345-010-0560-4","volume":"28","author":"MD Staehler","year":"2010","unstructured":"Staehler MD, Kruse J, Haseke N et al (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a\u00a0retrospective comparative analysis. World J Urol 28(4):543\u2013547","journal-title":"World J Urol"},{"issue":"4","key":"647_CR18","doi-asserted-by":"publisher","first-page":"e0151662","DOI":"10.1371\/journal.pone.0151662","volume":"11","author":"P Grassi","year":"2016","unstructured":"Grassi P, Doucet L, Giglione P et\u00a0al (2016) Clinical impact of pancreatic metastases from renal cell carcinoma: a multicenter retrospective analysis. PLoS ONE 11(4):e151662","journal-title":"PLoS ONE"},{"key":"647_CR19","first-page":"176373","volume":"2015","author":"X Yu","year":"2015","unstructured":"Yu X, Wang B, Li X et\u00a0al (2015) The significance of metastasectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy. Biomed Res Int 2015:176373","journal-title":"Biomed Res Int"},{"issue":"6","key":"647_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ddg.13247","volume":"15","author":"TK Eigentler","year":"2017","unstructured":"Eigentler TK, Muhlenbein C, Follmann M, Schadendorf D, Garbe C (2017) S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms \u2013 Update 2015\/2016, Kurzversion 2.0. J Dtsch Dermatol Ges 15(6):e1\u2013e41","journal-title":"J. Dtsch. Dermatol. Ges."},{"issue":"9","key":"647_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/bjs.9189","volume":"100","author":"JM Aubin","year":"2013","unstructured":"Aubin JM, Rekman J, Vandenbroucke-Menu F et al (2013) Systematic review and meta-analysis of liver resection for metastatic melanoma. Br J Surg 100(9):1138\u20131147","journal-title":"Br J Surg"},{"issue":"4","key":"647_CR22","first-page":"524","volume":"244","author":"R Adam","year":"2006","unstructured":"Adam R, Chiche L, Aloia T et\u00a0al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a\u00a0prognostic model. Ann Surg 244(4):524\u2013535","journal-title":"Ann Surg"},{"issue":"5","key":"647_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.0.CO;2-G","volume":"85","author":"S Eskelin","year":"1999","unstructured":"Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivela T (1999) Screening for metastatic malignant melanoma of the uvea revisited. Cancer 85(5):1151\u20131159","journal-title":"Cancer"},{"issue":"11","key":"647_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ejso.2009.02.016","volume":"35","author":"P Mariani","year":"2009","unstructured":"Mariani P, Piperno-Neumann S, Servois V et al (2009) Surgical management of liver metastases from uveal melanoma: 16 years\u2019 experience at the Institut Curie. Eur J Surg Oncol 35(11):1192\u20131197","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"647_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1056\/NEJMra1703413","volume":"377","author":"M Reck","year":"2017","unstructured":"Reck M, Rabe KF (2017) Precision diagnosis and treatment for advanced non-small-cell lung cancer. N\u00a0Engl J Med 377(9):849\u2013861","journal-title":"N Engl J Med"},{"issue":"1","key":"647_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1200\/JOP.2017.026500","volume":"14","author":"SJ Stephens","year":"2018","unstructured":"Stephens SJ, Moravan MJ, Salama JK (2018) Managing patients with oligometastatic non-small-cell lung cancer. J\u00a0Oncol Pract 14(1):23\u201331","journal-title":"J Oncol Pract"},{"issue":"12","key":"647_CR27","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR Jr., Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a\u00a0multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17(12):1672\u20131682","journal-title":"Lancet Oncol"},{"key":"647_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1262-y","author":"F Ishige","year":"2018","unstructured":"Ishige F, Takayama W, Chiba S et al (2018) Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver. Int J Clin Oncol. \n                    https:\/\/doi.org\/10.1007\/s10147-018-1262-y","journal-title":"Int J Clin Oncol"},{"key":"647_CR29","volume-title":"Bericht zum Krebsgeschehen in Deutschland 2017","author":"Robert-Koch-Institut","year":"2017","unstructured":"Robert-Koch-Institut (2017) Bericht zum Krebsgeschehen in Deutschland 2017"},{"issue":"6","key":"647_CR30","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a\u00a0combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115(6):1234\u20131244","journal-title":"Cancer"},{"key":"647_CR31","volume-title":"Therapie und Nachsorge maligner Ovarialtumoren, Langversion 2.0 2016, AWMF-Registernummer: 032\/035OL","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik","year":"2017","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik (2017) Therapie und Nachsorge maligner Ovarialtumoren, Langversion 2.0 2016, AWMF-Registernummer: 032\/035OL. \n                    http:\/\/leitlinienprogramm-onkologie.de\/Ovarialkarzinom.61.0.html\n                    \n                  . Zugegriffen: 15.04.2018"},{"issue":"3","key":"647_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ Driel van","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K et\u00a0al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N\u00a0Engl J Med 378(3):230\u2013240","journal-title":"N Engl J Med"},{"issue":"5","key":"647_CR33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00404-010-1750-4","volume":"284","author":"HJ Roh","year":"2011","unstructured":"Roh HJ, Kim DY, Joo WD et\u00a0al (2011) Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch Gynecol Obstet 284(5):1223\u20131229","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"647_CR34","first-page":"6919","volume":"35","author":"N Bacalbasa","year":"2015","unstructured":"Bacalbasa N, Balescu I, Dima S, Popescu I (2015) Long-term survivors after liver resection for ovarian cancer liver metastases. Anticancer Res 35(12):6919\u20136923","journal-title":"Anticancer Res"},{"issue":"7","key":"647_CR35","first-page":"4125","volume":"35","author":"N Bacalbasa","year":"2015","unstructured":"Bacalbasa N, Balescu I, Dima S, Brasoveanu V, Popescu I (2015) Pancreatic resection as part of cytoreductive surgery in advanced-stage and recurrent epithelial ovarian cancer\u2014a single-center experience. Anticancer Res 35(7):4125\u20134129","journal-title":"Anticancer Res"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-018-0647-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-018-0647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-018-0647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T01:34:27Z","timestamp":1557970467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-018-0647-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1007\/s00104-018-0647-9","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"16 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Wahba, D.\u00a0Stippel und C.\u00a0Bruns geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}